195 related articles for article (PubMed ID: 29802412)
1. The histamine H
Kotańska M; Kuder KJ; Szczepańska K; Sapa J; Kieć-Kononowicz K
Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):875-881. PubMed ID: 29802412
[TBL] [Abstract][Full Text] [Related]
2. KSK19 - Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice.
Kotańska M; Mika K; Reguła K; Szczepańska K; Szafarz M; Bednarski M; Olejarz-Maciej A; Nowak K; Latacz G; Mogilski S; Kuder KJ; Kieć-Kononowicz K; Sapa J
Biochem Pharmacol; 2019 Oct; 168():193-203. PubMed ID: 31295465
[TBL] [Abstract][Full Text] [Related]
3. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.
Poirier B; Bidouard JP; Cadrouvele C; Marniquet X; Staels B; O'Connor SE; Janiak P; Herbert JM
Diabetes Obes Metab; 2005 Jan; 7(1):65-72. PubMed ID: 15642077
[TBL] [Abstract][Full Text] [Related]
4. Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model.
Kotańska M; Mika K; Sałaciak K; Wheeler L; Sapa J; Kieć-Kononowicz K; Pytka K
Pharmacol Biochem Behav; 2020 Sep; 196():172974. PubMed ID: 32565240
[TBL] [Abstract][Full Text] [Related]
5. H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice.
Dudek M; Kuder K; Kołaczkowski M; Olczyk A; Żmudzka E; Rak A; Bednarski M; Pytka K; Sapa J; Kieć-Kononowicz K
Metab Brain Dis; 2016 Oct; 31(5):1023-9. PubMed ID: 27216278
[TBL] [Abstract][Full Text] [Related]
6. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
[TBL] [Abstract][Full Text] [Related]
7. Sericin as treatment of obesity: morphophysiological effects in obese mice fed with high-fat diet.
Kunz RI; Capelassi AN; Alegre-Maller ACP; Bonfleur ML; Ribeiro LFC; Costa RM; Natali MRM
Einstein (Sao Paulo); 2020; 18():eAO4876. PubMed ID: 31576909
[TBL] [Abstract][Full Text] [Related]
8. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review.
Leu-Semenescu S; Nittur N; Golmard JL; Arnulf I
Sleep Med; 2014 Jun; 15(6):681-7. PubMed ID: 24854887
[TBL] [Abstract][Full Text] [Related]
9. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
Looije NA; Risovic V; Stewart DJ; Debeyer D; Kutney J; Wasan KM
J Pharm Pharm Sci; 2005 Aug; 8(3):400-8. PubMed ID: 16401390
[TBL] [Abstract][Full Text] [Related]
10. Aqueous extract of Chrysobalanus icaco leaves, in lower doses, prevent fat gain in obese high-fat fed mice.
White PA; Cercato LM; Batista VS; Camargo EA; De Lucca W; Oliveira AS; Silva FT; Goes TC; Oliveira ER; Moraes VR; Nogueira PC; De Oliveira E Silva AM; Quintans-Junior LJ; Lima BS; Araújo AA; Santos MR
J Ethnopharmacol; 2016 Feb; 179():92-100. PubMed ID: 26723470
[TBL] [Abstract][Full Text] [Related]
11. Metabolic benefits of novel histamine H
Mika K; Szafarz M; Bednarski M; Kuder K; Szczepańska K; Pociecha K; Pomierny B; Kieć-Kononowicz K; Sapa J; Kotańska M
Biomed Pharmacother; 2021 Oct; 142():111952. PubMed ID: 34325303
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fat substitute, sucrose polyester, on food intake, body composition, and serum factors in lean and obese Zucker rats.
Grossman BM; Akoh CC; Hobbs JK; Martin RJ
Obes Res; 1994 May; 2(3):271-8. PubMed ID: 16353428
[TBL] [Abstract][Full Text] [Related]
13. B Vitamins Can Reduce Body Weight Gain by Increasing Metabolism-related Enzyme Activities in Rats Fed on a High-Fat Diet.
Zheng Y; Ma AG; Zheng MC; Wang QZ; Liang H; Han XX; Schouten EG
Curr Med Sci; 2018 Feb; 38(1):174-183. PubMed ID: 30074168
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan.
Henry MB; Zheng S; Duan C; Patel B; Vassileva G; Sondey C; Lachowicz J; Hwa JJ
Endocrinology; 2011 Mar; 152(3):828-35. PubMed ID: 21239440
[TBL] [Abstract][Full Text] [Related]
15. Antiobesity effects of yerba maté extract (Ilex paraguariensis) in high-fat diet-induced obese mice.
Arçari DP; Bartchewsky W; dos Santos TW; Oliveira KA; Funck A; Pedrazzoli J; de Souza MF; Saad MJ; Bastos DH; Gambero A; Carvalho Pde O; Ribeiro ML
Obesity (Silver Spring); 2009 Dec; 17(12):2127-33. PubMed ID: 19444227
[TBL] [Abstract][Full Text] [Related]
16. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S
Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227
[TBL] [Abstract][Full Text] [Related]
17. Augmenting leptin circadian rhythm following a weight reduction in diet-induced obese rats: short- and long-term effects.
Buison A; Pellizzon M; Ordiz F; Jen KL
Metabolism; 2004 Jun; 53(6):782-9. PubMed ID: 15164329
[TBL] [Abstract][Full Text] [Related]
18. Niclosamide as an anti-obesity drug: an experimental study.
Al-Gareeb AI; Aljubory KD; Alkuraishy HM
Eat Weight Disord; 2017 Jun; 22(2):339-344. PubMed ID: 28271456
[TBL] [Abstract][Full Text] [Related]
19. Intermittent access to a sucrose solution impairs metabolism in obesity-prone but not obesity-resistant mice.
Soto M; Chaumontet C; Mauduit CD; Fromentin G; Palme R; Tomé D; Even P
Physiol Behav; 2016 Feb; 154():175-83. PubMed ID: 26596703
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
